Visgeneer, Inc. recalls Blood Uric Acid Monitoring System Each kit contains 1 meter

Due to products distributed without premarket clearance or approvals.

On 12/04/2023, the firm sent an email titled, "FDA notification about eBuricacid" to its distibutors informing them that Visgeneer has received a notice from FDA that the eBuricacid/Uritouch Blood uric acid monitors are not cleared to be marketed/distributed within the U.S. and is requesting that the products (kits and strips) be delisted from Amazon site as soon as possible. An additional email was sent to distributors on 06/23/2025 and 07/01/2025 as a follow up to the 12/04/2023 email - requesting for information on the quantities of monitors/kits and strips that were removed from Amazon, and instructing the distributor to destroy the stock of affected products on hand and noting that the strips are expired.

• FDA enforcement recordOfficial FDA database entry for Z-2501-2025
• FDA device classification · PTCOfficial FDA classification for this device type
• CFR regulation · 21 CFR 862.1775The federal regulation governing this device
• FDA recall announcementSearch FDA.gov for the official press announcement
• Find Visgeneer, Inc.Search for the manufacturer's official notice
• News coverageRecent reporting on this recall and manufacturer
• openFDA data recordThe raw JSON record this page is built from

Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.